1998•Unpublished venueRequires access

Stable long term transfected human hepatocellular carcinoma cell line bearing HSV 1 thymidine kinase gene by retroviral vector

Wei Chen

Open publisher page 0 citations

Abstract

The recombinant retroviral vector pLTRNL containing the HSV 1 TK gene was transfected into human hepatocellular carcinoma cell line hHCC by lipofectamine method. The transfected cells were selected with 800mg/L of geneticin(G418) for three weeks, and then cloned and subcloned. G418 resistant transfected cells were named hHCC/TK cells. The total RNA and genomic DNA of hHCC/TK or hHCC were extracted. These genomic DNA containing TK gene were identified by PCR. The total RNA containing mRNA of HSV 1 TK gene were identified by RT PCR and RNA slot blot methods. The results showed that the HSV 1 TK gene was integrated into the genomc of transfected cells and the mRNA of TK gene has been transcribed. The establishment of stable long term transfected human hepatocellular carcinoma cell line bearing HSV 1 TK gene could provide the possibility of experimental gene therapy for human hepatocellular carcinoma in vitro and in vivo .

About this research paper

What this paper is about

The recombinant retroviral vector pLTRNL containing the HSV 1 TK gene was transfected into human hepatocellular carcinoma cell line hHCC by lipofectamine method. The transfected cells were selected with 800mg/L of geneticin(G418) for three weeks, and then cloned and subcloned. G418 resistant transfected cells were named hHCC/TK cells. The total RNA and genomic DNA of hHCC/TK or hHCC were extracted. These genomic DNA containing TK gene were identified by PCR. The total RNA containing mRNA of HSV 1 TK gene were identified by RT PCR and RNA slot blot methods. The results showed that the HSV 1 TK gene was integrated into the genomc of transfected cells and the mRNA of TK gene has been transcribed. The establishment of stable long term transfected human hepatocellular carcinoma cell line bearing HSV 1 TK gene could provide the possibility of experimental gene therapy for human hepatocellular carcinoma in vitro and in vivo .

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The recombinant retroviral vector pLTRNL containing the HSV 1 TK gene was transfected into human hepatocellular carcinoma cell line hHCC by lipofectamine method. The transfected cells were selected with 800mg/L of geneticin(G418) for three weeks, and then cloned and subcloned. G418 resistant transfected cells were named hHCC/TK cells. The total RNA and genomic DNA of hHCC/TK or hHCC were extracted. These genomic DNA containing TK gene were identified by PCR. The total RNA containing mRNA of HSV 1 TK gene were identified by RT PCR and RNA slot blot methods. The results showed that the HSV 1 TK gene was integrated into the genomc of transfected cells and the mRNA of TK gene has been transcribed. The establishment of stable long term transfected human hepatocellular carcinoma cell line bearing HSV 1 TK gene could provide the possibility of experimental gene therapy for human hepatocellular carcinoma in vitro and in vivo .

Key concepts: Lipofectamine, Transfection, Molecular biology, Biology, Thymidine kinase, Genetic enhancement, Viral vector, Gene

Related papers

Back to paper searchBrowse research topicsOriginal source
Stable long term transfected human hepatocellular carcinoma cell line bearing HSV 1 thymidine kinase gene by retroviral vector — Research Paper | ScholarLens